[{"id":"c124e77c-6bb2-4053-bf1f-8c73601ac88f","acronym":"FOKAL-BT","url":"https://clinicaltrials.gov/study/NCT02391051","created_at":"2021-01-18T11:24:01.627Z","updated_at":"2024-07-02T16:37:18.932Z","phase":"Phase 2","brief_title":"Focal Brachytherapy in Patients With Selected \"Low-risk\" Prostate Cancer - a Phase-II-trial","source_id_and_acronym":"NCT02391051 - FOKAL-BT","lead_sponsor":"University of Erlangen-Nürnberg Medical School","biomarkers":" FGFR1 • CDKN1A • MIR141","pipe":"","alterations":" ","tags":["FGFR1 • CDKN1A • MIR141"],"overall_status":"Recruiting","enrollment":" Enrollment 50","initiation":"Initiation: 10/01/2014","start_date":" 10/01/2014","primary_txt":" Primary completion: 12/01/2019","primary_completion_date":" 12/01/2019","study_txt":" Completion: 12/01/2029","study_completion_date":" 12/01/2029","last_update_posted":"2017-08-11"}]